FINWIRES · TerminalLIVE
FINWIRES

Mayne Pharma Group Receives AU$14.4 Million from Cosette Pharmaceuticals for Legal Costs

By

Mayne Pharma Group (ASX:MYX) confirmed that it received AU$14.4 million from Cosette Pharmaceuticals in accordance with the Supreme Court of New South Wales' orders, comprising recovery of Mayne's legal costs, costs associated with Mayne's application for costs, and interest, according to a Friday Australian bourse filing.

The company began proceedings against Cosette in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025. The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette.

An appeal against the October 2025 judgment by Cosette was heard in the Supreme Court of New South Wales, Court of Appeal on Tuesday and Wednesday, and a decision was reserved.

Its shares rose over 1% in recent trading on Friday.

Related Articles

Asia

Yest Wins KRW22.8 Billion Semiconductor Manufacturing Equipment Order from Samsung Electronics; Shares Rise 6%

Yest (KOSDAQ:122640) secured an order for optical communication network equipment from Samsung Electronics (KRX:005930), according to a Thursday filing with the Korea Exchange.The contract, valued at 22.82 billion won, is valid till Dec. 30, 2027.Shares of Yest rose nearly 6% in recent trade.

KOSDAQ:122640KRX:005930
Asia

LiComm Wins Optical Communication Network Equipment Order from 1Finity; LiComm Shares Jump 30%

Electronics manufacturer LiComm (KOSDAQ:388790) secured an order for optical communication network equipment from Fujitsu (TYO:6702) subsidiary and telecommunications and network solutions firm 1Finity, according to a Thursday filing with the Korea Exchange.The contract, valued at 3.87 billion won, is valid till Dec. 6, 2027.Shares of LiComm jumped nearly 30% in recent trade, while those of Fujitsu fell nearly 3%.

KOSDAQ:388790TYO:6702
Asia

Guoco Group to Develop Singapore Property via JV

Guoco Group (HKG:0053) agreed to set up a joint venture with real estate firms, Intrepid and TIDR, to develop a residential project in Singapore's Lentor Central, according to a Wednesday filing with the Hong Kong bourse.The project, which involves a property acquired for HK$4.03 billion via tender, spans 15,925.8 square meters and could potentially yield 562 residential units,Guoco will acquire a 50% interest in the joint venture, Intrepid will own 40%, while TIDR will take the remaining 10%.The partners will contribute HK$1.45 billion to the venture in proportion to their ownership of the JV. In Guoco's case, the capital contribution will amount to HK$724.4 million, comprising HK$165.4 million in share capital and HK$559 million in loans.A further HK$3.89 billion was arranged to finance part of the property's acquisition cost and the project's future construction costs and working capital.Guoco also agreed to provide project management and services to the project under a separate agreement that would expire on June 2, 2029.Intrepid and TIDR are associated with Guoco through its substantial shareholder Hong Leong Investment Holdings.

HKG:0053